perindopril has been researched along with Cardiometabolic Syndrome in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (73.33) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Batacan, R; Connolly, K; Fenning, A; Jackson, D; Vella, R | 1 |
| Brzozowska-Villatte, R; De Champvallins, M; Dézsi, CA; Farsang, C; Glezer, M; Karpov, Y | 1 |
| Bel'sner, MS; Blinova, EV; Ignatova, GL | 1 |
| Guillausseau, PJ; Lameira, D; Mourad, JJ | 1 |
| Khadipash, LA; Kiseleva, NV; Kosmatova, OV; Mamedov, MN; Oganov, RG; Perova, NV | 1 |
| Cao, G; DeRosa, G; Forcada, P; Toblli, JE | 1 |
| Aksenov, KV; Filimonov, MA; Trusov, VV | 1 |
| Bugriĭ, ME; Chazova, IE; Gornostaev, VV; Mychka, VB; Sergienko, VB | 1 |
| Safar, ME | 1 |
| Bertrand, M; Daly, CA; Ferrari, R; Fox, KM; Hildebrandt, P; Remme, W; Simoons, M | 1 |
| Cao, G; Mastai, R; Mella, J; Muñoz, MC; Pereyra, L; Toblli, JE | 1 |
| Statsenko, ME; Zemlianskaia, MM | 1 |
| Cheema, FA; Khan, BV; Khan, QA; Rahman, ST; Vaccari, CS | 1 |
| Kinoshita, M; Matsumoto, T; Matsuo, S; Nakamura, Y; Takahashi, M | 1 |
1 review(s) available for perindopril and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Beneficial Effects of a Perindopril/Indapamide Single-Pill Combination in Hypertensive Patients with Diabetes and/or Obesity or Metabolic Syndrome: A Post Hoc Pooled Analysis of Four Observational Studies.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Drug Combinations; Humans; Hypertension; Indapamide; Metabolic Syndrome; Middle Aged; Obesity; Perindopril; Treatment Outcome | 2021 |
6 trial(s) available for perindopril and Cardiometabolic Syndrome
| Article | Year |
|---|---|
[Correction of Metabolic Syndrome in Patients With Severe Chronic Obstructive Pulmonary Disease].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Echocardiography; Electrocardiography; Follow-Up Studies; Forced Expiratory Volume; Humans; Male; Metabolic Syndrome; Middle Aged; Perindopril; Pulmonary Disease, Chronic Obstructive; Risk Factors; Severity of Illness Index | 2015 |
Blood pressure normalization by fixed perindopril/indapamide combination in hypertensive patients with or without associate metabolic syndrome: results of the OPTIMAX 2 study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diuretics; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Metabolic Syndrome; Middle Aged; Perindopril; Prospective Studies; Time Factors; Treatment Outcome | 2008 |
[Correction of endothelial dysfunction by noliprel in patients with metabolic syndrome].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Combinations; Endothelium, Vascular; Female; Humans; Indapamide; Male; Metabolic Syndrome; Middle Aged; Perindopril | 2005 |
Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Body Mass Index; Coronary Artery Disease; Diabetes Mellitus; Europe; Female; Humans; Lipids; Male; Metabolic Syndrome; Middle Aged; Obesity; Perindopril; Prognosis; Risk Assessment | 2007 |
[Effect of a fixed combination of perindopril and indapamide on 24-hour blood pressure profile, morpho-functional parameters of the heart, heart rate variability, functional state of the kidney, and quality of life in patients with arterial hypertension c
Topics: Aged; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Kidney; Male; Metabolic Syndrome; Middle Aged; Perindopril; Quality of Life; Treatment Outcome | 2007 |
Effects of angiotensin-converting enzyme inhibitor therapy on levels of inflammatory markers in response to exercise-induced stress: studies in the metabolic syndrome.
Topics: Adult; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; CD11b Antigen; Double-Blind Method; Exercise Test; Female; Humans; Interleukin-6; Male; Metabolic Syndrome; Middle Aged; Perindopril; Vascular Cell Adhesion Molecule-1 | 2008 |
8 other study(ies) available for perindopril and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Perindopril prevents development of obesity and hypertension in middle aged diet-induced obese rat models of metabolic syndrome.
Topics: Animals; Blood Pressure; Diet, High-Fat; Hypertension; Male; Metabolic Syndrome; Obesity; Perindopril; Rats; Rats, Inbred WKY | 2023 |
[Low-dose combination of perindopril arginine with indapamide in correction of metabolic syndrome].
Topics: Antihypertensive Agents; Comorbidity; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Metabolic Syndrome; Middle Aged; Perindopril | 2011 |
[Effect of combined antihypertensive and lipid lowering therapy on the level of coronary risk and tissue insulin resistance in patients with metabolic syndrome].
Topics: Adult; Antihypertensive Agents; Atenolol; Atorvastatin; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Female; Fenofibrate; Heptanoic Acids; Humans; Hypolipidemic Agents; Indapamide; Male; Metabolic Syndrome; Middle Aged; Perindopril; Pyrroles; Simvastatin; Treatment Outcome | 2003 |
Reduced cardiac expression of plasminogen activator inhibitor 1 and transforming growth factor beta1 in obese Zucker rats by perindopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Collagen; Disease Models, Animal; Male; Metabolic Syndrome; Myocardium; Obesity; Organ Size; Perindopril; Plasminogen Activator Inhibitor 1; Rats; Rats, Zucker; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
[Cerebral and myocardial perfusion in patients with arterial hypertension and metabolic syndrome after monotherapy with combined drug noliprel].
Topics: Angiotensin-Converting Enzyme Inhibitors; Brain; Cerebrovascular Circulation; Coronary Circulation; Diuretics; Drug Combinations; Female; Heart; Humans; Hypertension; Indapamide; Male; Metabolic Syndrome; Perindopril; Radionuclide Imaging; Treatment Outcome | 2006 |
Pulse pressure: a help in medical semiology for metabolic syndrome.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Blood Pressure Determination; Heart Rate; Humans; Hypertension; Metabolic Syndrome; Perindopril; Pulse | 2007 |
ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats.
Topics: Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Disease Models, Animal; Fatty Liver; Interleukin-6; Irbesartan; Liver; Liver Cirrhosis; Male; Metabolic Syndrome; Obesity; Perindopril; Rats; Rats, Zucker; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2008 |
Detection of coronary microvascular disease by means of cardiac scintigraphy.
Topics: Aged; Cardiac Catheterization; Chest Pain; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Humans; Isosorbide Dinitrate; Metabolic Syndrome; Perindopril; Pravastatin; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2002 |